APR 01, 2021 4:22 PM PDT

Injection Treats Childhood Blindness

WRITTEN BY: Nouran Amin

A patient with a genetic-based childhood blindness has gained vision after receiving an experimental RNA therapeutic treatment in the form of a single injection. The clinical trial was performed by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania. The therapy was intended to treat diagnoses of Leber congenital amaurosis (LCA) which involves an eye disorder that affects the retina. These disorders are likely a result of patients being born with a CEP290 mutation-- one of the most implicated genes.

This form of LCA suffer causes severe visual impairment that typically begins in infancy.

"Our results set a new standard of what biological improvements are possible with antisense oligonucleotide therapy in LCA caused by CEP290 mutations," said co-lead author Artur V. Cideciyan, PhD, a research professor of Ophthalmology. "Importantly, we established a comparator for currently-ongoing gene editing therapies for the same disease, which will allow comparison of the relative merits of two different interventions."

Findings were published in Nature Medicine and shows how treatment via the injection known as sepofarsen leads to marked changes at the fovea which is the locus point of human central vision.

"This work represents a really exciting direction for RNA antisense therapy. It's been 30 years since there were new drugs using RNA antisense oligonucleotides, even though everybody realized that there was great promise for these treatments," said Jacobson. "The unexpected stability of the ciliary transition zone noted in the patient prompts reconsideration of dosing schedules for sepofarsen, as well as other cilium-targeted therapies."

Learn more about childhood blindness:

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
OCT 08, 2021
Cannabis Sciences
The Synergistic Mystery of the Entourage Effect
OCT 08, 2021
The Synergistic Mystery of the Entourage Effect
The entourage effect is a much talked about characteristic attributed with the unique psychoactive effects associated wi ...
OCT 19, 2021
Immunology
Reverse Vaccinations Tame the Immune System to Help Hemophilia Patients
OCT 19, 2021
Reverse Vaccinations Tame the Immune System to Help Hemophilia Patients
In patients with hemophilia A—a hereditary disorder where the blood cannot clot properly—their immune system ...
OCT 28, 2021
Immunology
Unlocking a New Target to Treat Gut Inflammation
OCT 28, 2021
Unlocking a New Target to Treat Gut Inflammation
  Immunologists have uncovered a molecular switch in T cells that serves as a prime target for therapeuti ...
NOV 04, 2021
Drug Discovery & Development
Transcranial Magnetic Stimulation Improves Depression in 80% Patients
NOV 04, 2021
Transcranial Magnetic Stimulation Improves Depression in 80% Patients
A novel form of transcranial magnetic stimulation (TMS) treatment improves symptoms of depression within days of treatme ...
NOV 30, 2021
Drug Discovery & Development
Enabling new levels of quantification with the SCIEX 7500 system - powered by SCIEX OS Software
NOV 30, 2021
Enabling new levels of quantification with the SCIEX 7500 system - powered by SCIEX OS Software
Sensitivity is a fundamental performance characteristic of a mass spectrometer The SCIEX 7500 system is enabling new lev ...
NOV 30, 2021
Cannabis Sciences
To Trust or Not to Trust the Process: Bioreactive Chemical Variation in Cannabis Extracts Based on Extraction Method
NOV 30, 2021
To Trust or Not to Trust the Process: Bioreactive Chemical Variation in Cannabis Extracts Based on Extraction Method
With cannabis legislation becoming increasingly less restrictive over the past 20 years, consumers have found themselves ...
Loading Comments...